Letter to the Malaysian government on tobacco control
The most important scientists on harm reduction research recently sent a letter to the government of Malaysia to alert them about the consequences that may derive from their proposed prohibition…
Polosa and Goniewicz the world’s most influential e-cigarette researchers, a new bibliometrics analysis concludes
The mapping of Global Research on electronic cigarettes showed that prof. Riccardo Polosa (CoEHAR Center of Excellence for the Acceleration of HArm Reduction, University of Catania) and prof. Maciej L. Goniewicz (Roswell Park Comprehensive Cancer Center, USA) are the most influential authors and the most important researchers in the e-cigarettes research field.
Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”
The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.
Replica Project: switching to ecig can restore vascular system repair mechanisms
CoEHAR researchers, involved in the Replica project, have shown that switching to electronic cigarettes and heated tobacco products reduce the vascular damage and the onset of diseases such as arteriosclerosis.
CoEHAR members calls for reconsider the vaping ban in Bangladesh and sign a letter to the Health Ministry
CoEHAR members, in collaboration with a group of international experts and THR advocates, signed a letter to “urge the government of Bangladesh not to prohibit smoke free nicotine-based alternatives to combustible cigarettes and to use evidence-based regulatory policy to do more to protect the health of Bangladesh's 164,7 million people”.
Evidence for Clinicians: E-Cigarettes a Better Chance at Health
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
Covid-19: ecig only add 1% of risk compared to breathing
Incredibly, people close to an infected vaper using an e-cigarette in home or restaurant scenarios face a one percent increase of risk of contagion compared to the control case of a normal breathing (without vaping) inside closed spaces. This relative added risk becomes 5-17 percent for high intensity vaping and up to 260 percent for speaking for various periods and coughing.
US: end of teen nicotine vaping epidemic and eradication of tobacco smoking
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes
A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus
The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
- Go to the previous page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- …
- 32
- Go to the next page
